ACETOHEXAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Acetohexamide patents expire, and what generic alternatives are available?
Acetohexamide is a drug marketed by Ani Pharms, Usl Pharma, and Watson Labs Teva. and is included in five NDAs.
The generic ingredient in ACETOHEXAMIDE is acetohexamide. There are six drug master file entries for this compound. Additional details are available on the acetohexamide profile page.
Summary for ACETOHEXAMIDE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 4 |
Patent Applications: | 5,051 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACETOHEXAMIDE at DailyMed |
Recent Clinical Trials for ACETOHEXAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Canadian Institutes of Health Research (CIHR) | |
Canadian Network for Observational Drug Effect Studies, CNODES | |
Drug Safety and Effectiveness Network, Canada |